Trial intelligence / Profile preview

Dexamethasone vs prednisone during induction in pediatric intermediate/high-risk ALL

ChiCTR2000036056Phase 3Not yet recruiting

Sponsor
Shanghai Children's Hospital
Start
Sep 2020
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in acute lymphoblastic leukemia (ALL) comparing Prednisone induction with Dexamethasone induction (2 arms). Primary endpoint: Event-free survival (EFS). Planned start Sep 2020; status: not yet recruiting.

02

Drugs

dexamethasoneprednisone
03

Conditions

acute lymphoblastic leukemia (ALL)

Beyond the preview

Go deeper on ChiCTR2000036056.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000036056.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call